Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

ZD 6126

X
Drug Profile

ZD 6126

Alternative Names: ANG-453; ZD-6126

Latest Information Update: 07 Jul 2011

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Angiogene Pharmaceuticals
  • Class Antineoplastics
  • Mechanism of Action Angiogenesis inhibitors; Tubulin inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • Available For Licensing Yes

Highest Development Phases

  • Suspended Solid tumours

Most Recent Events

  • 14 Feb 2005 A preclinical study has been added to the Cancer pharmacodynamics section
  • 03 Aug 2004 Preclinical studies in Solid tumours in the US - due to unexpected toxicity findings from phase II studies, ZD 6126 is now undergoing preclinical studies to explore scheduling options
  • 09 Oct 2003 Data presented at the 12th European Conference of Clinical Oncology (ECCO-2003) have been added to the pharmacokinetics and adverse events sections

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top